Additionally, we employed a CMP with documented antiovarian tumor activity (17), known to mimic a conserved sequence in claudin-4, resulting in its mislocalization (see Supplementary Fig. S1B; ref. 24). The gene discussed is CLDN4; the disease is neoplasm.